KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2016 - 2026)

Medpace Holdings filings provide 12 years of Liabilities and Shareholders Equity readings, the most recent being $2.1 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 12.24% to $2.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.4 billion, a 7.16% decrease, with the full-year FY2025 number at $2.0 billion, down 5.97% from a year prior.
  • Liabilities and Shareholders Equity hit $2.1 billion in Q1 2026 for Medpace Holdings, up from $2.0 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.1 billion in Q1 2026 to a low of $1.3 billion in Q2 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.7 billion (2023), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 18.52% in 2022 and later soared 40.18% in 2024.
  • Medpace Holdings' Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then rose by 22.5% to $1.7 billion in 2023, then rose by 26.8% to $2.1 billion in 2024, then dropped by 5.97% to $2.0 billion in 2025, then rose by 7.8% to $2.1 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $2.1 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.8 billion (Q3 2025) per Business Quant data.